Propranolol Accord 10 mg Norge - norsk - Statens legemiddelverk

propranolol accord 10 mg

accord healthcare b.v. - propranololhydroklorid - tablett, filmdrasjert - 10 mg

Propranolol Accord 40 mg Norge - norsk - Statens legemiddelverk

propranolol accord 40 mg

accord healthcare b.v. - propranololhydroklorid - tablett, filmdrasjert - 40 mg

Propranolol Accord 80 mg Norge - norsk - Statens legemiddelverk

propranolol accord 80 mg

accord healthcare b.v. - propranololhydroklorid - tablett, filmdrasjert - 80 mg

Pranolol 20 mg Norge - norsk - Statens legemiddelverk

pranolol 20 mg

actavis group ptc ehf (1) - propranololhydroklorid - tablett - 20 mg

Pranolol 40 mg Norge - norsk - Statens legemiddelverk

pranolol 40 mg

actavis group ptc ehf (1) - propranololhydroklorid - tablett - 40 mg

Pranolol 80 mg Norge - norsk - Statens legemiddelverk

pranolol 80 mg

actavis group ptc ehf (1) - propranololhydroklorid - tablett - 80 mg

Hemangiol Den europeiske union - norsk - EMA (European Medicines Agency)

hemangiol

pierre fabre medicament - propranolol hydroklorid - hemangiom - betablokkende midler - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.